Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance-Reference-Cited by-同舟云学术

Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

Published:2015-09 Issue:6 Volume:162 Page:1271-1285
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Hugo Willy,Shi Hubing,Sun Lu,Piva Marco,Song Chunying,Kong Xiangju,Moriceau Gatien,Hong Aayoung,Dahlman Kimberly B.,Johnson Douglas B.,Sosman Jeffrey A.,Ribas Antoni,Lo Roger S.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference32 articles.

1. Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma;Biechele;Sci. Signal.,2012

2. Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma;Ferrari de Andrade;Cancer Res.,2014

3. Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma;Girotti;Cancer Discov.,2013

4. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors;Gros;J. Clin. Invest.,2014

5. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation;Johannessen;Nature,2010

Cited by 519 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy Innovations for Melanoma;Hematology/Oncology Clinics of North America;2024-10

2. Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response;Pharmacology & Therapeutics;2024-10

3. Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy;Cell;2024-09

4. Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitors;eBioMedicine;2024-09

5. Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors;Cancers;2024-08-27